Comparative outcomes of vascular access in patients older than 70 years with end-stage renal disease

Objective

The advantage of arteriovenous fistulas (AVFs) in older patients requiring dialysis is controversial. We reviewed our vascular access experience in patients ≥70 years of age (older group) compared with younger patients.

Risk factors associated with postoperative prosthetic graft patency in Leriche syndrome

Background

In Leriche syndrome, postoperative graft thrombosis remains one of the most significant clinical challenges.

Use of the Covera Stent Graft for the Treatment of Dysfunctional or Thrombosed Arteriovenous Grafts: A Retrospective Analysis of 64 Patients

PurposeTo retrospectively evaluate the safety and effectiveness of the Covera stent graft (SG) for the treatment of dysfunctional or thrombosed arteriovenous grafts (AVGs).Materials and MethodsWithin 29 months (February 2016–August 2018), 79 patients underwent Covera SG placement in the authors’ department for the treatment of dysfunctional AVGs. Data were available for 64 patients who underwent 64 procedures, using 64 devices. Minimum follow-up was 6 months, unless reintervention occurred. Mean follow-up was 277 days (6–923 days). Treatment characteristics were 51 cases with venous-graft anastomosis (VGA) stenosis (79.7%), 13 cases of puncture zone stenosis (20.3%), 14 cases of in SG stenosis (21.9%), 8 cases of pseudoaneurysm treatment (12.5%) (1 treatment area might have had more than 1 characteristic). Thirty-six patients presented with thrombosis (56.2%), and 31 of 64 case were de novo treatment areas (48.4%). Primary outcome measurements were technical success and post-intervention primary patency (PIPP) at 6 months, whereas secondary outcome measurements included factors influencing primary outcome.ResultsTechnical success was 100%. Median PIPP was 336 days, and 73.6% of treatment areas were patent at 6 months. There were no significant differences in terms of PIPP when de novo treatment areas were compared with restenotic areas (519 vs. 320 days, respectively; P = .1); patients who presented with versus those who presented without thrombosis (320 vs. 583 days, respectively; P = .07); puncture zone stenosis or elsewhere (329 vs. 686 days, respectively; P = .52); and VGA stenosis or elsewhere (336 vs. 335 days, respectively; P = .9).ConclusionsUse of the Covera SG for AVG treatment was safe and effective in every type of treatment area presented in this retrospective analysis.     

Primary tubal choriocarcinoma

Choriocarcinoma is one of the most serious forms of gestational trophoblastic tumor. It is a malignant tumor from the epithelium of the chorionic villi. The most frequent location site is the uterus. Associated with ectopic pregnancy, it is extremely rare and in general, very aggressive. In 75% of the cases, it items from distant metastasis; therefore, a histological examination of the tubes must be performed in all ectopic pregnancies. Our patient was a 33-year-old woman who was admitted to emergency room (ER) with an intense pain in the right, iliac cavity, and limited genital bleeding. During the exploration, there was abdominal pain, with doubtful signs of peritoneal irritation. The vaginal ultrasound offered an image that was compatible with an extra uterine pregnancy in the left appendages. At emergency, right salpingectomy was performed via laparotomy. The patient was treated with polychemotherapy and contraceptives for a year, with no recurrence of the disease. Control follow-up was performed using beta-human chorionic gonadotropin (HCG) testing on a weekly basis during the first month and then bi-monthly during the first year of follow-up.     

输卵管妊娠的腹腔镜下保守性手术

目的　探讨输卵管妊娠在腹腔镜下保留输卵管的手术治疗效果。方法　应用腹腔镜对 2 8例输卵管妊娠病人 ,采用从输卵管妊娠部位开窗或输卵管破口处取胚 ,系膜下注射氨甲喋呤 (MTX)。结果　 2 8例输卵管妊娠流产型、破裂型、未破裂型等全部完成保留输卵管手术 ,血HCG术后 2周降至正常。其中 3例发生持续性妊娠 ,肌注MTX后痊愈。术后 2 0例行HSG或输卵管通水术 ,通畅 16例 ,术后再次宫内妊娠 6例。结论　腹腔镜保守性手术治疗输卵管妊娠可以保留输卵管及生育功能。     

Patency of the infarct-related coronary artery — a pertinent factor in late recovery of myocardial fatty acid metabolism among patients receiving thrombolytic therapy?

The decrease in mortality among patients receiving thrombolytic therapy for myocardial infarction is greater than would be expected from the improvement in left ventricular contractile function alone; thus some additional advantage of recanalization of the infarctrelated coronary artery probably exists. Changes in the post-infarction myocardial metabolic state with respect to artery patency have not been studied with a gamma camera previously. A single-photon emission tomography scan using the fatty acid analogue para-¹²³I-iodophenylpentadecanoic acid was performed at rest before hospital discharge on nine patients with first anterior myocardial infarction. All patients had received intravenous thrombolytic therapy at the beginning of the insult. The semiquantitative analysis of the left ventricle included a total of 44 segments in each patient. The test was repeated 3 months later, with the patients divided into two groups: six patients had an angiographically patent left anterior descending coronary artery (group A), and three an occluded artery (group B). In group A the number of myocardial segments with abnormal (<70% of maximum) fatty acid uptake was initially 20.2±4.7 (mean±SD) and was reduced to 11.3±6.1 during the follow-up (95% confidence interval of the decrease 16.0–1.7 segments). In group B the number of these aberrant segments was fairly constant (21.7±13.1, initial test, and 21.3±13.3, retest). Our preliminary results suggest that even when thrombolytic therapy fails to prevent myocardial infarction, myocardial fatty acid metabolism has a better change of recovering if the relevant coronary artery has regained its patency. This finding emphasizes the need for further study to establish whether a direct link exists between myocardial metabolic state and patient survival after infarction.     

Spirometry as an objective tool for nasal patency

Spirometry can be used as an objective tool for measuring nasal patency. it is sensitive, easy to perform, comfortable to patient The only limitation being that it only can be done in institution.     

输卵管绝育术后并发异位妊娠病因及其防治的探讨

本文总结我院２０年中输卵管绝育术后并发异位妊娠的有关临床资料，主要以陈旧性宫外孕为其临床特征，仍以停经、腹痛、阴道出血为主要症状，对绝育术致宫外孕的有关因素及其预防进行了分析探讨。     

天花粉治疗输卵管异位妊娠的效果与分析

目的:探讨输卵管异位妊娠采用天花粉针保守治疗的临床疗效及适应症。方法:为一次性肌注2mg并辅以地塞米松,然后观察其症状体征、血HCG、B超结果的变化情况。结果:通过对28例病例的治疗效果统计分析,对于血HCG低于1500mIU/ml、B超检查提示附件包块<2cm、停经时间<45d者,效果达100%;其余为89%。结论:天花粉治疗输卵管异位妊娠有较好的疗效。     

毛冬青甲素对大鼠实验性输卵管炎性阻塞的作用

本实验通过在大鼠输卵管腔内注入15%苯酚糊剂建立输卵管炎性阻塞模型,观察毛冬青甲素对该模型组织学和血液流变学的影响,旨在探讨毛冬青甲素对输卵管炎性阻塞的防治作用。结果表明:毛冬青甲素能抑制输卵管炎所致的结缔组织增生,对抗粘膜上皮的变性坏死,抑制炎症的浸润。用药组与对照组比较,差异有显著性意义(P<0.05～0.01)。同时,造模大鼠经用药后其血液比粘度、红细胞电泳率、红细胞聚集指数等指标显著改善。为毛冬青甲素治疗输卵管炎性阻塞提供了初步依据。